These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 21078540

  • 1. Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: role of Akt and nuclear factor-κB.
    Ma Y, Wang J, Liu L, Zhu H, Chen X, Pan S, Sun X, Jiang H.
    Cancer Lett; 2011 Feb 01; 301(1):75-84. PubMed ID: 21078540
    [Abstract] [Full Text] [Related]

  • 2. Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells.
    Chen KF, Yeh PY, Yeh KH, Lu YS, Huang SY, Cheng AL.
    Cancer Res; 2008 Aug 15; 68(16):6698-707. PubMed ID: 18701494
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells.
    Chen G, Wang K, Yang BY, Tang B, Chen JX, Hua ZC.
    Int J Oncol; 2012 Jan 15; 40(1):139-47. PubMed ID: 21947421
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Icariin synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
    Li W, Wang M, Wang L, Ji S, Zhang J, Zhang C.
    Cell Biochem Biophys; 2014 Mar 15; 68(2):427-36. PubMed ID: 23975599
    [Abstract] [Full Text] [Related]

  • 8. Arsenic trioxide potentiates the anti-cancer activities of sorafenib against hepatocellular carcinoma by inhibiting Akt activation.
    Zhai B, Jiang X, He C, Zhao D, Ma L, Xu L, Jiang H, Sun X.
    Tumour Biol; 2015 Apr 15; 36(4):2323-34. PubMed ID: 25416439
    [Abstract] [Full Text] [Related]

  • 9. Swainsonine inhibits growth and potentiates the cytotoxic effect of paclitaxel in hepatocellular carcinoma in vitro and in vivo.
    You N, Liu W, Wang T, Ji R, Wang X, Gong Z, Dou K, Tao K.
    Oncol Rep; 2012 Dec 15; 28(6):2091-100. PubMed ID: 22993037
    [Abstract] [Full Text] [Related]

  • 10. DHMEQ, a novel NF-kappaB inhibitor, induces apoptosis and cell-cycle arrest in human hepatoma cells.
    Nishimura D, Ishikawa H, Matsumoto K, Shibata H, Motoyoshi Y, Fukuta M, Kawashimo H, Goto T, Taura N, Ichikawa T, Hamasaki K, Nakao K, Umezawa K, Eguchi K.
    Int J Oncol; 2006 Sep 15; 29(3):713-9. PubMed ID: 16865289
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.
    Sreekanth CN, Bava SV, Sreekumar E, Anto RJ.
    Oncogene; 2011 Jul 14; 30(28):3139-52. PubMed ID: 21317920
    [Abstract] [Full Text] [Related]

  • 13. Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo.
    Hsu YL, Kuo PL, Tzeng TF, Sung SC, Yen MH, Lin LT, Lin CC.
    J Gastroenterol Hepatol; 2008 Jul 14; 23(7 Pt 2):e290-9. PubMed ID: 18522681
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I, Zhang H, Mizuta T, Ide Y, Eguchi Y, Yasutake T, Sakamaki T, Pestell RG, Yamamoto K.
    Clin Cancer Res; 2007 Apr 01; 13(7):2236-45. PubMed ID: 17404108
    [Abstract] [Full Text] [Related]

  • 16. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
    Wang W, Adachi M, Zhang R, Zhou J, Zhu D.
    Pancreas; 2009 May 01; 38(4):e114-23. PubMed ID: 19342982
    [Abstract] [Full Text] [Related]

  • 17. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.
    Liu Y, Poon RT, Li Q, Kok TW, Lau C, Fan ST.
    Cancer Res; 2005 May 01; 65(9):3691-9. PubMed ID: 15867364
    [Abstract] [Full Text] [Related]

  • 18. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation.
    Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, Aggarwal BB.
    Mol Pharmacol; 2006 Jan 01; 69(1):195-206. PubMed ID: 16219905
    [Abstract] [Full Text] [Related]

  • 19. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.
    Li T, Dong ZR, Guo ZY, Wang CH, Zhi XT, Zhou JW, Li DK, Chen ZT, Chen ZQ, Hu SY.
    Liver Int; 2015 Apr 01; 35(4):1416-29. PubMed ID: 25066210
    [Abstract] [Full Text] [Related]

  • 20. The role of NF-κB in PARP-inhibitor-mediated sensitization and detoxification of arsenic trioxide in hepatocellular carcinoma cells.
    Luo Q, Li Y, Lai Y, Zhang Z.
    J Toxicol Sci; 2015 Jun 01; 40(3):349-63. PubMed ID: 25972196
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.